# Freedom SOLO Stentless Heart Valve Study

Study · id `cardio:ct-nct01115907` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01115907](<https://clinicaltrials.gov/study/NCT01115907>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01115907

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 251 participants.

## Technical summary

Registry record NCT01115907. Allocation not applicable; no masking; primary purpose treatment. Start 2010-12 (registry gives no type); primary completion 2014-10 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 251 participants (enrolled count; ClinicalTrials.gov record NCT01115907, source copy `cardio:ctgov-nct01115907-2015-01-26`, retrieved 2026-10-26)
- Start date: 2010-12 (registry gives no type) (ClinicalTrials.gov record NCT01115907, source copy `cardio:ctgov-nct01115907-2015-01-26`, retrieved 2026-10-26)
- Primary completion: 2014-10 (actual) (ClinicalTrials.gov record NCT01115907, source copy `cardio:ctgov-nct01115907-2015-01-26`, retrieved 2026-10-26)
- Completion: 2014-10 (actual) (ClinicalTrials.gov record NCT01115907, source copy `cardio:ctgov-nct01115907-2015-01-26`, retrieved 2026-10-26)
- Countries: United States; Canada (ClinicalTrials.gov record NCT01115907, source copy `cardio:ctgov-nct01115907-2015-01-26`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01115907-2015-01-26`, retrieved 2026-10-26)

## The registry's words

- Brief title: Freedom SOLO Stentless Heart Valve Study
- Acronym: SOLO
- Condition: Aortic Stenosis
- Condition: Aortic Insufficiency
- Intervention (Device): Freedom SOLO Stentless Heart Valve
- Lead sponsor: Sorin Group USA, Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Aortic regurgitation (`cardio:aortic-regurgitation`)
- Registry condition terms include this condition: Aortic stenosis (`cardio:aortic-stenosis`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)

## Provenance

Content hash: 7c81833b12a0bdc6b6f8d9cc224e8cae6411a4acb1ef0b5059fbff168b0e1e60
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
